IBDEI0TN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13636,2)
 ;;=^5005539
 ;;^UTILITY(U,$J,358.3,13637,0)
 ;;=H33.322^^80^763^98
 ;;^UTILITY(U,$J,358.3,13637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13637,1,3,0)
 ;;=3^Round Hole,Left Eye
 ;;^UTILITY(U,$J,358.3,13637,1,4,0)
 ;;=4^H33.322
 ;;^UTILITY(U,$J,358.3,13637,2)
 ;;=^5005540
 ;;^UTILITY(U,$J,358.3,13638,0)
 ;;=H33.311^^80^763^48
 ;;^UTILITY(U,$J,358.3,13638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13638,1,3,0)
 ;;=3^Horseshoe Tear of Retina w/o Detachment,Right Eye
 ;;^UTILITY(U,$J,358.3,13638,1,4,0)
 ;;=4^H33.311
 ;;^UTILITY(U,$J,358.3,13638,2)
 ;;=^5005535
 ;;^UTILITY(U,$J,358.3,13639,0)
 ;;=H33.312^^80^763^49
 ;;^UTILITY(U,$J,358.3,13639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13639,1,3,0)
 ;;=3^Horseshoe Tear of Retina w/o Detachment,Left Eye
 ;;^UTILITY(U,$J,358.3,13639,1,4,0)
 ;;=4^H33.312
 ;;^UTILITY(U,$J,358.3,13639,2)
 ;;=^5005536
 ;;^UTILITY(U,$J,358.3,13640,0)
 ;;=H35.033^^80^763^50
 ;;^UTILITY(U,$J,358.3,13640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13640,1,3,0)
 ;;=3^Hypertensive Retinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,13640,1,4,0)
 ;;=4^H35.033
 ;;^UTILITY(U,$J,358.3,13640,2)
 ;;=^5005592
 ;;^UTILITY(U,$J,358.3,13641,0)
 ;;=H35.031^^80^763^52
 ;;^UTILITY(U,$J,358.3,13641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13641,1,3,0)
 ;;=3^Hypertensive Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,13641,1,4,0)
 ;;=4^H35.031
 ;;^UTILITY(U,$J,358.3,13641,2)
 ;;=^5005590
 ;;^UTILITY(U,$J,358.3,13642,0)
 ;;=H35.032^^80^763^51
 ;;^UTILITY(U,$J,358.3,13642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13642,1,3,0)
 ;;=3^Hypertensive Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,13642,1,4,0)
 ;;=4^H35.032
 ;;^UTILITY(U,$J,358.3,13642,2)
 ;;=^5005591
 ;;^UTILITY(U,$J,358.3,13643,0)
 ;;=H35.071^^80^763^90
 ;;^UTILITY(U,$J,358.3,13643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13643,1,3,0)
 ;;=3^Retinal Telangiectasis,Right Eye
 ;;^UTILITY(U,$J,358.3,13643,1,4,0)
 ;;=4^H35.071
 ;;^UTILITY(U,$J,358.3,13643,2)
 ;;=^5005606
 ;;^UTILITY(U,$J,358.3,13644,0)
 ;;=H35.072^^80^763^89
 ;;^UTILITY(U,$J,358.3,13644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13644,1,3,0)
 ;;=3^Retinal Telangiectasis,Left Eye
 ;;^UTILITY(U,$J,358.3,13644,1,4,0)
 ;;=4^H35.072
 ;;^UTILITY(U,$J,358.3,13644,2)
 ;;=^5005607
 ;;^UTILITY(U,$J,358.3,13645,0)
 ;;=H35.051^^80^763^88
 ;;^UTILITY(U,$J,358.3,13645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13645,1,3,0)
 ;;=3^Retinal Neovascularization,Right Eye
 ;;^UTILITY(U,$J,358.3,13645,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,13645,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,13646,0)
 ;;=H35.052^^80^763^87
 ;;^UTILITY(U,$J,358.3,13646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13646,1,3,0)
 ;;=3^Retinal Neovascularization,Left Eye
 ;;^UTILITY(U,$J,358.3,13646,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,13646,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,13647,0)
 ;;=H35.061^^80^763^92
 ;;^UTILITY(U,$J,358.3,13647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13647,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
 ;;^UTILITY(U,$J,358.3,13647,1,4,0)
 ;;=4^H35.061
 ;;^UTILITY(U,$J,358.3,13647,2)
 ;;=^5005602
 ;;^UTILITY(U,$J,358.3,13648,0)
 ;;=H35.062^^80^763^91
 ;;^UTILITY(U,$J,358.3,13648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13648,1,3,0)
 ;;=3^Retinal Vasculitis,Left Eye
 ;;^UTILITY(U,$J,358.3,13648,1,4,0)
 ;;=4^H35.062
 ;;^UTILITY(U,$J,358.3,13648,2)
 ;;=^5005603
 ;;^UTILITY(U,$J,358.3,13649,0)
 ;;=H34.13^^80^763^6
 ;;^UTILITY(U,$J,358.3,13649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13649,1,3,0)
 ;;=3^Central Retinal Artery Occlusion,Bilateral
